Amorphous trehalose as a superior lyoprotectant for high-temperature long-term storage of freeze-dried mRNA-lipid nanoparticles
Authors:
- Han GaoHGHan Gao
- Jun OuyangJOJun Ouyang
- Chaoyang DuCDChaoyang Du
- Qian ShaoQSQian Shao
- Wei-Jie FangWei-Jie Fang
- 14 October 2026
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 705
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Recent advances in freeze-drying technologies for mRNA vaccines against infectious diseasesInternational Journal of Pharmaceutics, 2025
- Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseasesJournal of Controlled Release, 2025
- Thin-film freeze-drying of an influenza virus hemagglutinin mRNA vaccine in unilamellar lipid nanoparticles with blebsJournal of Controlled Release, 2024
- Formulation of protein-loaded nanoparticles via freeze-dryingDrug Delivery and Translational Research, 2024
- Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapyJournal of Controlled Release, 2024
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperaturesJournal of Controlled Release, 2023
- Freeze-drying: A flourishing strategy to fabricate stable pharmaceutical and biological productsInternational Journal of Pharmaceutics, 2022
- Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimizationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2021
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stabilityInternational Journal of Pharmaceutics, 2021